Addressing infectious disease in a therapeutically relevant fashion requires an understanding of both the microbial virulence factors that contribute to the disease process and the manner in which these factors impact the host immunological and inflammatory response. Achieving this will provide an opportunity to develop novel strategies to influence the pathogen and/or host response in favor of the host, thereby providing a perfect opportunity for clinically relevant translational research. Thus, achieving this understanding continues to be the overall goal of our Center for Microbial Pathogenesis and Host Inflammatory Responses. The key element to accomplishing this is to assemble a critical mass of investigators, each under the mentorship of established senior faculty, whose research is consistent with this underlying scientific theme and the overall goals of our Center. The underlying hypothesis that ties these investigators together is that targeting diverse microbial pathogens in the context of their impact on immunological and inflammatory responses in their common human host will optimize opportunities for the elucidation of common themes with respect to the host response and its adverse consequences on the disease process. To this end, this application brings together as Project Leaders four investigators who focus on diverse microbial pathogens from the point of view of both the pathogens themselves and their impact on host inflammatory responses. To support these investigators, and to build a pipeline of new investigators whose research is consistent with our underlying scientific theme, we propose to provide an integrated and highly interactive faculty development plan for all Center investigators that leverages the resources developed during Phase I to enable our Phase II Project Leaders and other Center investigators to establish independently-funded research careers in an area consistent with this underlying theme (Aim 1); to utilize the Administrative and Scientific Development (Core A) and Research and Technical Advancement (Core B) cores developed during Phase I to continue to promote the scientific development of Center investigators and enhance the overall research infrastructure on the host campuses (Aim 2); and to build on the success of our Phase I efforts to recruit additional investigators whose research is consistent with the underlying scientific theme and promote the development of collaborative, synergistic research relationships among Center investigators (Aim 3). This will allow us to build on the success of Phase I Project Leaders to establish a self-sustaining Center for Microbial Pathogenesis and Host Inflammatory Responses.

Public Health Relevance

Infectious disease remains a persistent problem that impacts all medical specialties. This is particularly true in an era of increased resistance to antimicrobial agents. In this context, it is important to consider not just the pathogen, but also its impact on the body?s immunological and inflammatory response, which often plays a key role in defining the clinical outcome. Thus, investigating the complex interactions between microbial pathogens and their human hosts from the perspectives of both the pathogen itself and the host response has the potential to significantly enhance the ability to control the devastating consequences of many infectious diseases, including those caused by pathogens that are resistant to antibiotics.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM103625-09
Application #
9925782
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Davani, Behrous
Project Start
2012-08-15
Project End
2022-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Esteves, Pedro J; Abrantes, Joana; Baldauf, Hanna-Mari et al. (2018) The wide utility of rabbits as models of human diseases. Exp Mol Med 50:66
Stuart, Johnasha D; Holm, Geoffrey H; Boehme, Karl W (2018) Differential Delivery of Genomic Double-Stranded RNA Causes Reovirus Strain-Specific Differences in Interferon Regulatory Factor 3 Activation. J Virol 92:
Meeker, Daniel G; Wang, Tengjiao; Harrington, Walter N et al. (2018) Versatility of targeted antibiotic-loaded gold nanoconstructs for the treatment of biofilm-associated bacterial infections. Int J Hyperthermia 34:209-219
Jenkins, Samir V; Nedosekin, Dmitry A; Miller, Emily K et al. (2018) Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy. Int J Hyperthermia 34:19-29
Jenkins, Samir V; Vang, Kieng B; Gies, Allen et al. (2018) Sample storage conditions induce post-collection biases in microbiome profiles. BMC Microbiol 18:227
Lo, Dennis; Kennedy, Joshua L; Kurten, Richard C et al. (2018) Modulation of airway hyperresponsiveness by rhinovirus exposure. Respir Res 19:208
Latham, Jacob I; Blevins, Jon S (2018) Generation of Conditional Mutants in Borrelia burgdorferi. Methods Mol Biol 1690:225-239
Lei, Mei G; Lee, Chia Y (2018) Repression of Capsule Production by XdrA and CodY in Staphylococcus aureus. J Bacteriol 200:
Salinas, Eduardo; Gupta, Arundhati; Sifford, Jeffrey M et al. (2018) Conditional mutagenesis in vivo reveals cell type- and infection stage-specific requirements for LANA in chronic MHV68 infection. PLoS Pathog 14:e1006865
Winchell, Caylin G; Dragan, Amanda L; Brann, Katelynn R et al. (2018) Coxiella burnetii Subverts p62/Sequestosome 1 and Activates Nrf2 Signaling in Human Macrophages. Infect Immun 86:

Showing the most recent 10 out of 124 publications